Pyrimidine, quinazoline, pteridine and triazine derivatives
This invention is concerned with compounds of the formula wherein A, R1 to R5 and G are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The invention further relates to pharmaceutical compositions containing such compounds, to a process for their preparation and to their use for the treatment and/or prevention of diseases which are associated with the modulation of SST receptors subtype 5.
-
Page/Page column 26
(2008/06/13)
More Articles about upstream products of 951004-06-1